Danske Bank A S Acquires Shares of 98,694 The Cooper Companies, Inc. $COO

Danske Bank A S bought a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm bought 98,694 shares of the medical device company’s stock, valued at approximately $7,077,000. Danske Bank A S owned about 0.05% of Cooper Companies as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in COO. BlackRock Inc. bought a new position in Cooper Companies during the second quarter worth $1,077,762,000. State Street Corp raised its holdings in shares of Cooper Companies by 2.4% during the fourth quarter. State Street Corp now owns 8,793,747 shares of the medical device company’s stock worth $720,736,000 after purchasing an additional 207,195 shares during the period. Wellington Management Group LLP lifted its position in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the last quarter. Price T Rowe Associates Inc. MD lifted its position in shares of Cooper Companies by 58.8% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 6,028,821 shares of the medical device company’s stock worth $494,123,000 after buying an additional 2,231,568 shares during the last quarter. Finally, Sustainable Growth Advisers LP boosted its holdings in shares of Cooper Companies by 22.1% in the 3rd quarter. Sustainable Growth Advisers LP now owns 4,132,535 shares of the medical device company’s stock valued at $283,327,000 after buying an additional 747,476 shares during the period. 24.39% of the stock is currently owned by institutional investors.

Cooper Companies Price Performance

Shares of COO opened at $76.22 on Friday. The firm has a market capitalization of $14.87 billion, a price-to-earnings ratio of 64.59, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83. The stock’s fifty day moving average is $71.93 and its 200-day moving average is $71.16. The Cooper Companies, Inc. has a one year low of $58.89 and a one year high of $89.83. The company has a debt-to-equity ratio of 0.23, a quick ratio of 0.78 and a current ratio of 1.27.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. Cooper Companies’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities analysts anticipate that The Cooper Companies, Inc. will post 4.63 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on COO. Weiss Ratings downgraded shares of Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research report on Monday, June 8th. KeyCorp reissued a “sector weight” rating on shares of Cooper Companies in a report on Friday, June 5th. JPMorgan Chase & Co. decreased their target price on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating for the company in a research note on Friday, June 5th. Wall Street Zen raised Cooper Companies from a “hold” rating to a “buy” rating in a report on Sunday, June 21st. Finally, The Goldman Sachs Group set a $61.00 price target on Cooper Companies in a research report on Wednesday, May 27th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $81.64.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.